About this trial
Background:Following cardiac catheterization and arterial sheath removal, manual compression is applied until bleeding stops, after which a compression belt is used. Patients must lie supine for at least 6 hours, often experiencing discomfort including back pain, eating difficulties, and urinary problems. The compressed leg is restrained to prevent movement, adding to the discomfort. Despite adhering to this standard procedure, some patients still develop bleeding or hematomas after compression, requiring extended treatment. Current research on predicting compression duration and bleeding risk factors after femoral arterial sheath removal is limited and inconsistent. This study aims to identify factors that can more accurately predict necessary compression time after initial hemostasis, potentially reducing patient discomfort and complications such as prolonged bleeding, extended compression, and hematoma formation, which can impact vital signs.
Purpose:To understand the factors influencing complete hemostasis and supine duration after femoral arterial sheath removal in ICU patients.
Methods:Clinical data were collected through observation, and statistical analysis was performed using SPSS.
Expected Outcomes:To identify factors that influence complete hemostasis and supine duration after femoral arterial sheath removal in ICU patients, and to develop a prediction model that allows clinical units to accurately assess the required supine compression time following femoral arterial sheath removal.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients admitted to the cardiac intensive care unit of this hospital.
Patients undergoing femoral arterial sheath removal.
Age 20 years or older.
Disqualifiers
Patients unable to maintain supine position or refusing physical restraints.
Patients with severe hematoma, vascular rupture, or other vascular complications present at the femoral arterial puncture site at the time of sheath insertion.
Patients with a diagnosis of severe disseminated intravascular coagulation (DIC).
Trial population
1. Patients admitted to the cardiac intensive care unit of this institution 2. Patients requiring femoral arterial sheath removal
Trial design
Cohort
Cross-sectional
Treatments tested in this trial
Direct Inspection, medical records browsing
Diagnostic testInspect the puncture site directly and collect data from medical records.
Treatment groups
Trial outcomes
Primary outcomes
To understand the factors influencing complete hemostasis and supine duration after femoral arterial sheath removal in ICU patients.
This study is a correlational study, and its main objective is to identify the factors associated with the inability to achieve complete hemostasis within the standard time (defined as 6 hours).
Sponsors and contacts
Click on the lead sponsor to view all of their trials.